Immunohistochemical analysis of tumor budding as predictor of lymph node metastasis from superficial esophageal squamous cell carcinoma

[1] Kitagawa Y(2019)Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2 Esophagus 16 25-43

[2] Uno T(2015)Histopathological diagnoses of squamous intraepithelial neoplasia, carcinoma in situ and early invasive cancer of the oesophagus: the Japanese viewpoint Diagn Histopathol 21 303-311

[3] Oyama T(2018)Comparison of the guidelines for colorectal cancer in Japan, the USA and Europe Ann Gastroenterol Surg 2 6-12

[4] Arai T(2018)Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer Int J Clin Oncol 23 1-34

[5] Matsuda Y(2009)Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy Cancer 115 3324-3334

[6] Nishimura M(2008)Multivariate analysis of the pathologic features of esophageal squamous cell cancer: tumor budding is a significant independent prognostic factor Ann Surg Oncol 15 1977-1982

[7] Shinagawa T(2013)Tumor budding and E-cadherin expression are useful predictors of nodal involvement in T1 Esophageal squamous cell carcinoma Anticancer Res 33 5023-5030

[8] Tanaka T(2018)Immunohistochemical evaluation of tumor budding for stratifying T1 colorectal cancer: optimal cut-off value and a novel computer-assisted semiautomatic method Mod Pathol 32 675-683

[9] Nozawa H(2017)Japanese classification of esophageal cancer, 11th edition: part I Esophagus 14 1-36

[10] Watanabe T(2017)Recommendations for reporting tumor budding in colorectal cancer based on the international tumor budding consensus conference (ITBCC) 2016 Mod Pathol 30 1299-1311

[1] Kitagawa Y(2019)Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2 Esophagus 16 25-43

[2] Uno T(2015)Histopathological diagnoses of squamous intraepithelial neoplasia, carcinoma in situ and early invasive cancer of the oesophagus: the Japanese viewpoint Diagn Histopathol 21 303-311

[3] Oyama T(2018)Comparison of the guidelines for colorectal cancer in Japan, the USA and Europe Ann Gastroenterol Surg 2 6-12

[4] Arai T(2018)Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer Int J Clin Oncol 23 1-34

[5] Matsuda Y(2009)Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy Cancer 115 3324-3334

[6] Nishimura M(2008)Multivariate analysis of the pathologic features of esophageal squamous cell cancer: tumor budding is a significant independent prognostic factor Ann Surg Oncol 15 1977-1982

[7] Shinagawa T(2013)Tumor budding and E-cadherin expression are useful predictors of nodal involvement in T1 Esophageal squamous cell carcinoma Anticancer Res 33 5023-5030

[8] Tanaka T(2018)Immunohistochemical evaluation of tumor budding for stratifying T1 colorectal cancer: optimal cut-off value and a novel computer-assisted semiautomatic method Mod Pathol 32 675-683

[9] Nozawa H(2017)Japanese classification of esophageal cancer, 11th edition: part I Esophagus 14 1-36

[10] Watanabe T(2017)Recommendations for reporting tumor budding in colorectal cancer based on the international tumor budding consensus conference (ITBCC) 2016 Mod Pathol 30 1299-1311